These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12920396)

  • 1. Adenosine A1 receptor antagonists and the kidney.
    Modlinger PS; Welch WJ
    Curr Opin Nephrol Hypertens; 2003 Sep; 12(5):497-502. PubMed ID: 12920396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of adenosine A1-receptor antagonists in congestive heart failure.
    Gottlieb SS
    Drugs; 2001; 61(10):1387-93. PubMed ID: 11558828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A1 receptor antagonists in clinical research and development.
    Hocher B
    Kidney Int; 2010 Sep; 78(5):438-45. PubMed ID: 20592713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of macula densa adenosine triphosphate (ATP) in tubuloglomerular feedback.
    Ren Y; Garvin JL; Liu R; Carretero OA
    Kidney Int; 2004 Oct; 66(4):1479-85. PubMed ID: 15458441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of adenosine A1-receptor blockade with 8-cyclopentyl-1,3-dipropylxanthine in hypoxemic newborn rabbits.
    Prévot A; Mosig D; Rijtema M; Guignard JP
    Pediatr Res; 2003 Sep; 54(3):400-5. PubMed ID: 12788985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A(2) receptors modulate tubuloglomerular feedback.
    Carlström M; Wilcox CS; Welch WJ
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F412-7. PubMed ID: 20519378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine and kidney function: potential implications in patients with heart failure.
    Vallon V; Miracle C; Thomson S
    Eur J Heart Fail; 2008 Feb; 10(2):176-87. PubMed ID: 18242127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A1 receptor-dependent and independent pathways in modulating renal vascular responses to angiotensin II.
    Gao X; Peleli M; Zollbrecht C; Patzak A; Persson AE; Carlström M
    Acta Physiol (Oxf); 2015 Jan; 213(1):268-76. PubMed ID: 25251152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats.
    Puri N; Mohey V; Singh M; Kaur T; Pathak D; Buttar HS; Singh AP
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):361-8. PubMed ID: 26728617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic adenosine-mediated activation of hepatorenal reflex is via A1 receptors in rats.
    Ming Z; Lautt WW
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1177-84. PubMed ID: 17218982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecto-5'-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo.
    Huang DY; Vallon V; Zimmermann H; Koszalka P; Schrader J; Osswald H
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F282-8. PubMed ID: 16525161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adenosine antagonism in the cardio-renal syndrome: pathophysiology and therapeutic potential.
    Rajaram V; Joseph J
    Curr Heart Fail Rep; 2007 Sep; 4(3):153-7. PubMed ID: 17883991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
    Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S
    J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine type 1 receptor antagonists in fluid retaining disorders.
    Welch WJ
    Expert Opin Investig Drugs; 2002 Nov; 11(11):1553-62. PubMed ID: 12437502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of adenosine 1a receptor signaling on GFR early after the induction of sepsis.
    Street JM; Koritzinsky EH; Bellomo TR; Hu X; Yuen PST; Star RA
    Am J Physiol Renal Physiol; 2018 May; 314(5):F788-F797. PubMed ID: 29117994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of hepatic adenosine A1 receptors to renal dysfunction associated with acute liver injury in rats.
    Ming Z; Fan YJ; Yang X; Lautt WW
    Hepatology; 2006 Oct; 44(4):813-22. PubMed ID: 17006917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A1 antagonists and the cardiorenal syndrome.
    Gottlieb SS
    Curr Heart Fail Rep; 2008 Jun; 5(2):105-9. PubMed ID: 18765081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A1 receptor antagonist blunts urinary potassium excretion, but not renal hemodynamic effects, induced by carbonic anhydrase inhibitor in rats.
    Zhou X; Kost CK
    J Pharmacol Exp Ther; 2006 Feb; 316(2):530-8. PubMed ID: 16278313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.